Given the functional overlap between NHE1 and BCL-2 family-regulated pathways, we hypothesized that NHE1 may contribute to venetoclax resistance in AML by maintaining pHi and activating survival pathways such as PI3K/Akt. This evidence concerns the gene SLC9A1 and acute myeloid leukemia.